Evolent Health, Inc. EVH Amortization of deferred commissions
Amortization of deferred commissions at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CapitalizedContractCostAmortization.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s amortization of deferred commissions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s amortization of deferred commissions?
- Evolent Health, Inc. (EVH) reported amortization of deferred commissions of $931K in Q1 2026.
- How has Evolent Health, Inc.'s amortization of deferred commissions changed year-over-year?
- Evolent Health, Inc.'s amortization of deferred commissions decreased by 24.7% year-over-year, from $1.24M to $931K.
- What is the long-term trend for Evolent Health, Inc.'s amortization of deferred commissions?
- Over 4 years (2021 to 2025), Evolent Health, Inc.'s amortization of deferred commissions has grown at a -15.0% compound annual growth rate (CAGR), from $13.04M to $6.79M.
- What does amortization of deferred commissions mean?
- Represents the systematic expensing of capitalized costs incurred to obtain customer contracts over the expected period of benefit. This non-cash charge aligns the recognition of sales acquisition costs with the revenue generated from those specific contracts.